Lenz Robert A. (CIK 1992908) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-02-20). Recent activity: Sell NMRA (5,614 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-20 | Neumora Therapeutics, Inc. (NMRA) | Head of R&D | Sell | 5,614 | $9,375 |
Source: SEC Form 4 filings · as of 2025-02-20